Form 4: MYOMO CEO Paul Gudonis Granted Over 157,000 Restricted Stock Units

MYOMO, Inc. Chief Executive Officer and Director Paul R. Gudonis was granted 157,342 Restricted Stock Units (RSUs) as part of the company's 2018 Stock Option and Incentive Plan.

Summary

• Paul R. Gudonis, the Chief Executive Officer and a Director of MYOMO, INC. (MYO), acquired 157,342 shares of Common Stock.
• The transaction occurred on June 11, 2025, and represents a grant of Restricted Stock Units (RSUs) under the Issuer's 2018 Stock Option and Incentive Plan.
• The RSUs were granted at a price of $0 per share, which is typical for RSU grants.
• These RSUs are scheduled to vest in three equal annual installments, with the first vesting date beginning on June 11, 2026.
• Following this transaction, Paul R. Gudonis beneficially owns a total of 1,209,013 shares of Common Stock.

Sentiment

Score: 7

Explanation: The grant of RSUs to the CEO is generally a positive signal as it aligns management's interests with shareholders and promotes long-term retention. It is a standard compensation practice and does not indicate any immediate negative financial implications.

Positives

• The grant of Restricted Stock Units aligns the interests of the CEO, Paul R. Gudonis, with those of the shareholders, as the value of the RSUs is tied to the company's stock performance.
• The vesting schedule over three years indicates a commitment to long-term executive retention and performance.

Future Outlook

The granted Restricted Stock Units are set to vest in three equal annual installments starting on June 11, 2026, indicating a future equity payout tied to continued service and potentially performance.

Management Comments

• The grant of 157,342 Restricted Stock Units to CEO Paul R. Gudonis is part of the Issuer's 2018 Stock Option and Incentive Plan, reflecting a standard component of executive compensation designed to incentivize long-term performance and retention.

Industry Context

The grant of Restricted Stock Units (RSUs) to a Chief Executive Officer is a common practice in the technology and medical device industries, including companies like MYOMO, Inc., as a form of long-term incentive compensation. This aligns executive interests with shareholder value creation over time.

Comparison to Industry Standards

• RSU grants are a standard component of executive compensation packages across various industries, including medical technology, similar to practices seen in companies like InMode Ltd. (INMD) or Accuray Incorporated (ARAY) for their executives.
• The vesting schedule of three equal annual installments is a typical structure for such grants, aiming to retain key executives over a multi-year period, consistent with industry benchmarks for executive retention programs.

Corporate Governance

Related Party Transactions

• The grant of Restricted Stock Units to Paul R. Gudonis, the Chief Executive Officer and a Director, constitutes a related party transaction as it involves compensation provided by the company to a key executive.

Stakeholder Impact

• Shareholders: The RSU grant aligns the CEO's financial incentives with the company's long-term stock performance, potentially benefiting shareholders through improved executive motivation and retention.
• Employees: While not directly impacting all employees, executive compensation practices can influence overall company culture and compensation philosophy.
• Management: The CEO receives a significant equity stake, incentivizing continued leadership and performance.

Next Steps

• The granted Restricted Stock Units will begin to vest in three equal annual installments starting on June 11, 2026.

Key Dates

Keywords

MYOMO, MYO, SEC Form 4, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Paul R. Gudonis, Stock Grant, Equity Incentive Plan